SUBSCRIBE
SUBSCRIBE
News   Drug Development

VGX Pharmaceuticals (Formerly Known as Viral Genomix, Inc.)’ Oral Anti-Inflammatory Drug Safe in Phase I Study

March 26, 2009 | 
1 min read
Clinical research Phase 1
MORE ON THIS TOPIC
Insights
From Grants to Family Offices: Building a Unified Financing Strategy in Biotech
March 5, 2026
 · 
1 min read
 · 
Jennifer Smith-Parker
Podcast
UniQure’s Delay, REGENXBIO’s Rejection Explained, Sarepta’s Ingram Steps Down, More
March 4, 2026
 · 
1 min read
 · 
Heather McKenzie
cloud with rain of coins on blue background. minimal concept of investment, success and cryptocurrencies. 3d rendering
Insights
Rethinking Biotech’s Valley of Death as Federal Grants and Family Offices Step In
March 4, 2026
 · 
3 min read
 · 
Jennifer Smith-Parker
IN PARTNERSHIP WITH MEDSIR
Webinar: The Future is Collaborative: Transforming Clinical Trials
March 3, 2026
 · 
1 min read
 · 
BioSpace Insights